Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.03 Analyst target: $18.00 Upside: 124.16%
Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune systems of cancer patients. The company is headquartered in Waltham, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.